ideSHislider

ideSHi successfully hosted the Dissemination Program of the TCV Campaign at the SSQ Conference Hall, ideSHi, bringing together key stakeholders to share campaign insights, achievements, and lessons learned from the field. At the beginning of the program, Dr. Md. Rofiqur Rahman, COO, ideSHi briefly highlighted ideSHi’s overall activities and contributions to the TCV campaign. Following

ideSHi is pleased to host a productive and engaging session with representatives from leading pharmaceutical companies. The session opened with Dr. Md. Rofiqur Rahman, COO of ideSHi, who introduced ideSHi’s vision and strengths. This was followed by Dr. Umme Kulsum, Lead of the CRO Unit, who outlined ideSHi’s role as a CRO, highlighting its value

The Cervical Cancer Elimination Consortium Bangladesh, hosted by the Institute for Developing Science and Health Initiatives (ideSHi), organized a seminar on 29th November, 2025 to observe World Cervical Cancer Elimination Day 2025. The event was held at the SSQ Conference Hall, ideSHi, with the aim of accelerating national efforts toward the elimination of cervical cancer

17th November, 2025 On World Cervical Cancer Elimination Day, ideSHi celebrated with a vibrant rally, awareness Olympiad, survivor experience sharing, discussion session, and prize giving at Dhaka Cantonment Board Adarsha Biddya Niketon. Every year, 8,268 women in Bangladesh are diagnosed with cervical cancer—the highest death rate in Southeast Asia. Speakers emphasized that prevention through HPV

ideSHi recently organized a dissemination session at the EPI (Expanded Program on Immunization) office, attended by the Program Manager and Line Director of EPI Bangladesh, along with representatives from UNICEF Bangladesh, PATH, and other EPI officials. The session was highly encouraging, with ideSHi receiving positive feedback for its ongoing HPV awareness campaign. As HPV remains

At ideSHi, we offer advanced cancer diagnostics using NGS and RT-PCR platforms. Our panels cover Breast, Ovarian, Lung (EGFR, ALK, BRAF) and Colorectal (KRAS, NRAS, BRAF) cancers, along with solid tumor panels for Pancreatic, Prostate, Thyroid, Endometrial, Bladder, and more. We also provide HPV genotyping (23 types) using swab samples. Our goal is to deliver

Last week, Dr. Jonathan Hoffmann from Fondation Mérieux paid an insightful visit to ideSHi and its PneumoDX study sites within the FDMN camps in Ukhiya, Cox’s Bazar. The agenda was rich with activity—spanning appraisal of ongoing fieldwork, review of study progress, and exploration of prospective research collaborations. During Dr. Jonathan Hoffmann’s visit to ideSHi, Dr. Firdausi Qadri

WHO and UNICEF’s 2024 global immunization data (WUENIC) shows 85% of children worldwide received basic vaccines — a positive step forward. But millions are still being left behind. Awareness and easy access to vaccines are key to closing this gap. Every child deserves protection, no matter where they live.